133 related articles for article (PubMed ID: 31630877)
41. Validation of a new screening strategy for anti-extractable nuclear antigen antibodies.
Van Praet JT; Vander Cruyssen B; Bonroy C; Smith V; Delanghe J; De Keyser F
Clin Exp Rheumatol; 2009; 27(6):971-6. PubMed ID: 20149314
[TBL] [Abstract][Full Text] [Related]
42. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.
Strassburg CP; Alex B; Zindy F; Gerken G; Lüttig B; Meyer zum Büschenfelde KH; Bréchot C; Manns MP
J Hepatol; 1996 Dec; 25(6):859-66. PubMed ID: 9007714
[TBL] [Abstract][Full Text] [Related]
43. Induction of Autoantibodies and Autoimmune Diseases in Patients with Psoriasis Receiving Tumor Necrosis Factor Inhibitors.
Oter-López B; Llamas-Velasco M; Sánchez-Pérez J; Dauden E
Actas Dermosifiliogr; 2017 Jun; 108(5):445-456. PubMed ID: 28267955
[TBL] [Abstract][Full Text] [Related]
44. Prevalence and Clinical Significance of Anti-DFS70 in Antinuclear Antibody (ANA)-positive Patients Undergoing Routine ANA Testing in a New Zealand Public Hospital.
Lucas S; Chang WL; Merien F
J Rheumatol; 2018 Feb; 45(2):289-291. PubMed ID: 29419453
[No Abstract] [Full Text] [Related]
45. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
46. Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluation--a homogeneous, multiplexed system.
Gilburd B; Abu-Shakra M; Shoenfeld Y; Giordano A; Bocci EB; delle Monache F; Gerli R
Clin Dev Immunol; 2004 Mar; 11(1):53-6. PubMed ID: 15154612
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
48. Extractable nuclear antigen autoantibodies and their association with other autoantibodies and thymoma in myasthenia gravis.
Warlow R; Garlepp M; Dawkins R
J Neuroimmunol; 1985 May; 8(2-3):185-97. PubMed ID: 3873473
[TBL] [Abstract][Full Text] [Related]
49. Ro 52kD autoantibodies are detected in a subset of ANA-negative sera.
Pourmand N; Blomberg S; Rönnblom L; Karlsson-Parra A; Pettersson I; Wahren-Herlenius M
Scand J Rheumatol; 2000; 29(2):116-23. PubMed ID: 10777125
[TBL] [Abstract][Full Text] [Related]
50. Non-organ-specific autoimmunity in adult 47,XXY Klinefelter patients and higher-grade X-chromosome aneuploidies.
Panimolle F; Tiberti C; Spaziani M; Riitano G; Lucania G; Anzuini A; Lenzi A; Gianfrilli D; Sorice M; Radicioni AF
Clin Exp Immunol; 2021 Sep; 205(3):316-325. PubMed ID: 33978253
[TBL] [Abstract][Full Text] [Related]
51. The relationship between antinuclear antibody data and antibodies against extractable nuclear antigens in a large laboratory cohort.
Craig WY; Ledue TB
Clin Chem Lab Med; 2011 Nov; 50(3):497-502. PubMed ID: 22098438
[TBL] [Abstract][Full Text] [Related]
52. Detection and identification of significant ANAs in previously determined ANA negative samples.
Kidd K; Cusi K; Mueller R; Goodner M; Boyes B; Hoy E
Clin Lab; 2005; 51(9-10):517-21. PubMed ID: 16285474
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of the LIA-ANA-Profile-17S for the detection of autoantibodies to nuclear antigens.
Yi A; Lee CH; Moon HW; Kim H; Hur M; Yun YM
Clin Biochem; 2018 May; 55():75-79. PubMed ID: 29608892
[TBL] [Abstract][Full Text] [Related]
54. Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.
Bentow C; Swart A; Wu J; Seaman A; Manfredi M; Infantino M; Benucci M; Lakos G; Mahler M
Clin Chim Acta; 2013 Sep; 424():141-7. PubMed ID: 23727029
[TBL] [Abstract][Full Text] [Related]
55. The Clinical Relevance of Anti-DFS70 Autoantibodies.
Conrad K; Röber N; Andrade LE; Mahler M
Clin Rev Allergy Immunol; 2017 Apr; 52(2):202-216. PubMed ID: 27350273
[TBL] [Abstract][Full Text] [Related]
56. Comparison of two extractable nuclear antigen testing algorithms: ALBIA versus ELISA/line immunoassay.
Chandratilleke D; Silvestrini R; Culican S; Campbell D; Byth-Wilson K; Swaminathan S; Lin MW
Pathology; 2016 Aug; 48(5):491-7. PubMed ID: 27316331
[TBL] [Abstract][Full Text] [Related]
57. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases.
Eissfeller P; Sticherling M; Scholz D; Hennig K; Lüttich T; Motz M; Kromminga A
Ann N Y Acad Sci; 2005 Jun; 1050():327-39. PubMed ID: 16014549
[TBL] [Abstract][Full Text] [Related]
58. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
59. Utility of repeat extractable nuclear antigen antibody testing: a retrospective audit.
Yeo AL; Leech M; Ojaimi S; Morand E
Rheumatology (Oxford); 2023 Mar; 62(3):1248-1253. PubMed ID: 35916723
[TBL] [Abstract][Full Text] [Related]
60. Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study.
Akmatov MK; Röber N; Ahrens W; Flesch-Janys D; Fricke J; Greiser H; Günther K; Kaaks R; Kemmling Y; Krone B; Linseisen J; Meisinger C; Moebus S; Obi N; Guzman CA; Conrad K; Pessler F
Arthritis Res Ther; 2017 Jun; 19(1):127. PubMed ID: 28587625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
